Network medicine in disease analysis and therapeutics

Clinical Pharmacology and Therapeutics

Volumn 94, Issue 6, 2013, Pages 627-629

  Chen, B ^a   Butte, A J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CRIZOTINIB; DABRAFENIB; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; IRINOTECAN; PACLITAXEL; TRASTUZUMAB;

BREAST CANCER; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG DEVELOPMENT; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KNOCKOUT GENE; LUNG NON SMALL CELL CANCER; MELANOMA; METASTATIC COLORECTAL CANCER; MOLECULE; NATIONAL HEALTH ORGANIZATION; PHARMACEUTICAL CARE; PHYSICAL DISEASE BY BODY FUNCTION; PRIORITY JOURNAL; REVIEW;

DATABASES, FACTUAL; DISEASE; DRUG DISCOVERY; DRUG REPOSITIONING; DRUG THERAPY; DRUG THERAPY, COMBINATION; HUMANS; INDIVIDUALIZED MEDICINE; MOLECULAR TARGETED THERAPY; SYSTEMS BIOLOGY; TRANSCRIPTOME;

EID: 84887963766     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.181     Document Type: Review

References (10)

1. Barabasi, A.L., Gulbahce, N. & Loscalzo, J. Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 12, 56-68 (2011).
2. The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
3. Goh, K.I., Cusick, M.E., Valle, D., Childs, B., Vidal, M. & Barabasi, A.L. The human disease network. Proc. Natl. Acad. Sci. USA 104, 8685-90 (2007). (Pubitemid 47175372)
4. Suthram, S., Dudley, J.T., Chiang, A.P., Chen, R., Hastie, T.J. & Butte, A.J. Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Comput. Biol. 6, e1000662 (2010).
5. Ware, K.E. et al. A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop. Oncogenesis 2, e39 (2013).
6. Hopkins, A.L. Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 4, 682-690 (2008).
7. Lee, M.J. et al. Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell 149, 780-794 (2012).
8. Iskar, M. et al. Characterization of drug-induced transcriptional modules: towards drug repositioning and functional understanding. Mol. Syst. Biol. 9, 662 (2013).
9. Sirota, M. et al. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci. Transl. Med. 3, 96ra77 (2011).
10. Ramasamy, A., Mondry, A., Holmes, C.C. & Altman, D.G. Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med. 5, e184 (2008).